Instil Bio, Inc.
TIL
$7.61
$0.030.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 79.91% | 85.09% | 31.14% | 40.98% | -43.42% |
| Total Depreciation and Amortization | 1,966.67% | -97.59% | -98.38% | -98.67% | -98.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -87.09% | -92.17% | -79.12% | -79.88% | 167.38% |
| Change in Net Operating Assets | 58.52% | -64.16% | 103.14% | 107.94% | -393.45% |
| Cash from Operations | 68.62% | 68.13% | 32.99% | 47.56% | -39.38% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -97.19% | 0.00% | -97.60% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,381.11% | -103.44% | -38.41% | -57.38% | -103.63% |
| Cash from Investing | 1,422.75% | -103.30% | -39.86% | -57.37% | -103.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | 137.74% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Financing | -- | -- | -100.00% | 137.74% | -- |
| Foreign Exchange rate Adjustments | -95.24% | -111.63% | 70.77% | -159.52% | 362.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 107.66% | -129.15% | -81.80% | -1,388.98% | -754.43% |